Prescribing of psychotropic medications to patientswithout a psychiatric diagnosis

Psychiatric Services

Volumn 64, Issue 12, 2013, Pages 1243-1248

  Wiechers, Ilse R ^a   Leslie, Douglas L ^c   Rosenheck, Robert A ^b  

^a ROBERT WOOD JOHNSON FOUNDATION   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AMOXAPINE; AMPHETAMINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; CENTRAL STIMULANT AGENT; CHLORAL HYDRATE; CHLORDIAZEPOXIDE; CHLORPROMAZINE; CLOMIPRAMINE; CLONAZEPAM; CLORAZEPATE; CLOZAPINE; DESIPRAMINE; DESVENLAFAXINE; DEXAMPHETAMINE; DEXMETHYLPHENIDATE; DIAZEPAM; ESTAZOLAM; FLUPHENAZINE; HALOPERIDOL; LAMOTRIGINE; LISDEXAMFETAMINE; LITHIUM; LOXAPINE; NEUROLEPTIC AGENT; OXCARBAZEPINE; UNINDEXED DRUG; VALPROATE SEMISODIUM;

ABSENCE; ADULT; ARTICLE; FEMALE; GENERAL PRACTICE; HEALTH CARE; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS;

ADULT; COMORBIDITY; DATABASES, FACTUAL; DRUG PRESCRIPTIONS; FEMALE; HUMANS; INSURANCE, HEALTH; MALE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; MIDDLE AGED; PSYCHOTROPIC DRUGS; SEVERITY OF ILLNESS INDEX;

EID: 84888856412     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/appi.ps.201200557     Document Type: Article

References (17)

1. Pincus HA, Tanielian TL, Marcus SC, et al: Prescribing trends in psychotropic medications: primary care, psychiatry, and other medical specialties. JAMA 279:526-531, 1998
2. America's State of Mind. Washington, DC, Medco Health Solutions, 2011. Available at apps.who.int/medicinedocs/en/m/abstract/Js19032en
3. Mojtabai R: Increase in antidepressant medication in the US adult population between 1990 and 2003. Psychotherapy and Psychosomatics 77:83 - 92, 2008
4. Mark TL, Levit KR, Buck JA: Pychotropic drug prescriptions by medical specialty. Psychiatric Services 60:1167, 2009
5. Mojtabai R, Olfson M: National patterns in antidepressant treatment by psychiatrists and general medical providers: results from the National Comorbidity Survey Replication. Journal of Clinical Psychiatry 69:1064-1074, 2008
6. Mojtabai R, Olfson M: Proportion of antidepressants prescribed without a psychiatric diagnosis is growing. Health Affairs 30:1434-1442, 2011
7. Pagura J, Katz LY, Mojtabai R, et al: Antidepressant use in the absence of common mental disorders in the general population. Journal of Clinical Psychiatry 72:494-501, 2011
8. Milea D, Verpillat P, Guelfucci F, et al: Prescription patterns of antidepressants: findings from a US claims database. Current Medical Research and Opinion 26:1343-1353, 2010
9. Larson MJ, Miller K, Fleming KJ: Treatment with antidepressant medications in private health plans. Administration and Policy in Mental Health and Mental Health Services Research 34:116-126, 2007
10. Maust DT, Mavandadi S, Eakin A, et al: Telephone-based behavioral health assessment for older adults starting a new psychiatric medication. American Journal of Geriatric Psychiatry 19:851-858, 2011
11. Olfson M, Blanco C, Liu SM, et al: National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Archives of General Psychiatry 69:1247-1256, 2012
12. Charlson ME, Pompei P, Ales KL, et al: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. Journal of Chronic Diseases 40:373-383, 1987
13. Rost K, Smith R, Matthews DB, et al: The deliberate misdiagnosis of major depression in primary care. Archives of Family Medicine 3:333-337, 1994
14. Freeman VG, Rathore SS, Weinfurt KP, et al: Lying for patients: physician deception of third-party payers. Archives of Internal Medicine 159:2263- 2270, 1999
15. Fournier JC, DeRubeis RJ, Hollon SD, et al: Antidepressant drug effects and depression severity: a patient-level meta-analysis. JAMA 303:47-53, 2010
16. Gibbons RD, Hur K, Brown CH, et al: Benefits from antidepressants: synthesis of 6-week patient-level outcomes from double-blind placebo-controlled randomized trials of fluoxetine and venlafaxine. Archives of General Psychiatry 69:572-579, 2012
17. Kirsch I, Deacon BJ, Huedo-Medina TB, et al: Initial severity and antidepressant benefits: a meta-analysis of data submitted to the Food and Drug Administration. PLoS Medicine 5:e45, 2008